At just 0.15 mg/mL, egg-derived peptides (EPs) from American shad (Alosa sapidissima) extended Caenorhabditis elegans lifespan by 33.33% while improving motility metrics — head thrashing (+24.37%), body bending (+22.33%), and pharyngeal pumping (+28.81%) — alongside a 40.34% reduction in lipofuscin and ROS accumulation. SOD activity rose 53% while MDA dropped 30.76%. Transcriptomic profiling identified 2,196 differentially expressed genes, with EP upregulating unsaturated fatty acid biosynthesis genes (fat-7, elo-4) for membrane fluidity optimization and downregulating β-oxidation genes (acs-2, acox-1.5, ech-9, hacd-1) alongside stress-response genes (sod-3, hsp-16.1, hsf-1).
The lipid-remodeling angle is what distinguishes this work from the crowded field of peptide antioxidant studies. Most bioactive peptide longevity research anchors mechanistically to DAF-16/FOXO or TOR pathways; this study's transcriptomic data points instead toward membrane composition as a primary aging lever — consistent with the membrane pacemaker hypothesis of aging, which links polyunsaturated fatty acid profiles to metabolic rate and lifespan across species. The downregulation of stress-response genes like sod-3 and hsf-1, counterintuitively alongside reduced oxidative damage, suggests EP may reduce the basal oxidative burden rather than merely upregulating compensatory defenses. Critical limitations apply: C. elegans is a short-lived invertebrate with no circulatory system, and peptide bioavailability through mammalian digestion remains uncharacterized. The effect sizes are impressive but must be viewed as hypothesis-generating for human application. Incrementally promising, not yet paradigm-shifting.
